Results 211 to 220 of about 51,767 (241)

A Rare Lung Nodule Consisting of Adenocarcinoma and Amyloid Deposition in a Patient with Primary Systemic AL Amyloidosis

, 2011
Daigo Miyazaki, Masahide Yazaki, Wataru Ishii, Masayuki Matsuda, Yoshinobu Hoshii, Kenji Nara, Jun Nakayama, Shu‐ichi Ikeda   +7 more
openalex   +2 more sources

Association between CMR‐derived hepatic T1‐time, tricuspid regurgitation and survival

European Journal of Clinical Investigation, Volume 56, Issue 1, January 2026.
We investigated the association between tricuspid regurgitation (TR) severity and hepatic T1‐time in 1029 patients undergoing cardiac MRI and echocardiography. Hepatic T1‐time increased progressively with TR severity and remained independently associated after adjusting for NT‐proBNP and right ventricular function. Both TR and hepatic T1‐time predicted
Katharina Mascherbauer, Christina Kronberger, Manuel Gruber, Carolina Donà, Matthias Koschutnik, Varius Dannenberg, Michael Poledniczek, Laura Lunzer, Christian Nitsche, Franz Duca, Gregor Heitzinger, Kseniya Halavina, Dietrich Beitzke, Christian Loewe, Michael Trauner, Philipp Bartko, Julia Mascherbauer, Christian Hengstenberg, Andreas Kammerlander, Elisabeth Waldmann   +19 more
wiley   +1 more source

Beyond the Usual Suspects: Clinical and Pathological Insights From a Rare Case of Light Chain (AL) Amyloidosis in a Filipino Patient. [PDF]

Cureus
Cabataña GJ, Cebrecus JP, Ponce S, Rafanan AL, Saranza G.   +4 more
europepmc   +1 more source

Central nervous system involvement in cardiac amyloidosis: Redefining the heart‐brain axis

European Journal of Clinical Investigation, Volume 56, Issue 1, January 2026.
Central nervous system involvement in cardiac amyloidosis. Amyloidosis is a systemic disease that can directly affect the central nervous system. Furthermore, the amyloid cardiomyopathy can indirectly affect the central nervous system by inducing systemic hypoperfusion and increasing the risk of acute ischaemic stroke.
Domenico Mario Giamundo, Giuliano Cassataro, Stefano Ministrini, Simon F. Stämpfli   +3 more
wiley   +1 more source

Improved survival with daratumumab-CyBorD compared with CyBorD as frontline therapy for AL amyloidosis. [PDF]

Blood Neoplasia
Yohannan B, Rees M, Gertz MA, Dispenzieri A, Kapoor P, Buadi FK, Dingli D, Leung N, Lacy MQ, Hayman SR, Gonsalves W, Kourelis T, Cook J, Binder M, Siddiqui M, Lin Y, Hwa L, Rogers MG, Hobbs M, Fonder A, Warsame R, Rajkumar SV, Kumar SK, Muchtar E.   +23 more
europepmc   +1 more source

Early Detection of Central Nervous System Involvement in ATTRv Using Multimodal MRI and Cognitive Assessments

European Journal of Neurology, Volume 33, Issue 1, January 2026.
Multimodal MRI uncovers early signs of central nervous system damage in patients with ATTRv, including asymptomatic carriers. White matter structural changes detected through DTI represent a highly sensitive early biomarker of central impairment, likely linked to TTR amyloid angiopathy.
Renan Flávio de França Nunes, Thiago Junqueira Ribeiro de Rezende, Guilherme Soares de Oliveira Wertheimer, Wilson Marques Junior, Marcondes Cavalcante França Junior   +4 more
wiley   +1 more source

Amyloid Light-Chain (AL) Amyloidosis in a Middle-Aged Lady: Confronting the Challenges of a Rare Diagnosis in a Developing Country. [PDF]

Cureus
Piyarathna C, Samaraweera Y, Ranasinghe N, Piyasundara L, Mujahieth MI.   +4 more
europepmc   +1 more source

Serum Visfatin Level and Cardiac Valve Calcifcation in Hemodialysis Patients

Hemodialysis International, Volume 30, Issue 1, Page 101-109, January 2026.
ABSTRACT Background Cardiac valve calcification is a serious complication in patients with cardiovascular disease. This study investigated the relationship between visfatin levels and cardiac valve calcification in individuals undergoing hemodialysis.
Xiaoqi Wang, Dan Yuan, Feng Shao, Conghui Liu, Xiao Zhang, Zhongxin Li   +5 more
wiley   +1 more source

Case report: a case of AL amyloidosis with spontaneous giant retroperitoneal hematoma. [PDF]

Int J Emerg Med
Sheng Y, Zhu H.
europepmc   +1 more source

The Immunological Consequences of Clonal Hematopoiesis in Heart Failure

Immunological Reviews, Volume 337, Issue 1, January 2026.
ABSTRACT Inflammation is increasingly recognized as a central driver of heart failure (HF), particularly in older adults, yet the underlying immune mechanisms remain diverse and incompletely understood. Clonal hematopoiesis (CH), defined by the expansion of somatically mutated hematopoietic clones, has emerged as a risk factor for the development of ...
Megan A. Evans, Kenneth Walsh
wiley   +1 more source